Assetmark, Inc Charles River Laboratories International, Inc. Transaction History

Assetmark, Inc

$47.4 Billion
Q4 2025

A detailed history of Assetmark, Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 43,809 shares of CRL stock, worth $7.35 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

43,809

Previous 37,143 17.95%

Holding current value

$7.35 Million

Previous $5.81 Million 26.5%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 23, 2026	BUY	$167.03 - $197.04 $1.11 Million - $1.31 Million	6,666 Added 17.95%	43,809 $7.35 Million
Q3 2025 Nov 06, 2025	BUY	$145.57 - $178.99 $917,236 - $1.13 Million	6,301 Added 20.43%	37,143 $5.81 Million
Q2 2025 Aug 04, 2025	BUY	$99.75 - $151.89 $1.85 Million - $2.82 Million	18,557 Added 151.05%	30,842 $4.68 Million
Q1 2025 May 06, 2025	BUY	$150.52 - $190.14 $377,805 - $477,251	2,510 Added 25.68%	12,285 $1.85 Million
Q4 2024 Feb 06, 2025	BUY	$178.58 - $220.69 $1.71 Million - $2.12 Million	9,587 Added 5099.47%	9,775 $1.8 Million

Q3 2024 Nov 01, 2024	BUY	$187.96 - $245.29 $32,517 - $42,435	173 Added 1153.33%	188 $37,000
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $1,857 - $2,418	9 Added 150.0%	15 $3,000
Q1 2024 May 06, 2024	BUY	$203.52 - $273.43 $1,221 - $1,640	6 New	6 $1,000
Q1 2023 May 05, 2023	SELL	$191.89 - $259.92 $575 - $779	-3 Reduced 18.75%	13 $2,000
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $16,863 - $23,899	-66 Reduced 80.49%	16 $5,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $5,270 - $6,730	15 Added 22.39%	82 $31,000
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $17,061 - $21,555	58 Added 644.44%	67 $25,000
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $86,635 - $103,919	-347 Reduced 97.47%	9 $3,000
Q4 2020 Feb 10, 2021	BUY	$222.0 - $252.62 $38,406 - $43,703	173 Added 94.54%	356 $89,000
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $22,296 - $28,759	127 Added 226.79%	183 $41,000
Q2 2020 Aug 11, 2020	SELL	$118.84 - $189.72 $26,857 - $42,876	-226 Reduced 80.14%	56 $10,000
Q1 2020 May 12, 2020	BUY	$98.9 - $178.34 $15,626 - $28,177	158 Added 127.42%	282 $36,000
Q4 2019 Feb 11, 2020	BUY	$126.05 - $152.76 $15,252 - $18,483	121 Added 4033.33%	124 $19,000
Q3 2019 Nov 13, 2019	SELL	$125.07 - $143.67 $875 - $1,005	-7 Reduced 70.0%	3 $0
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $1,234 - $1,485	10 New	10 $1,000
Q1 2019 May 14, 2019	SELL	$104.82 - $146.73 $419 - $586	-4 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$105.09 - $137.23 $315 - $411	-3 Reduced 42.86%	4 $0
Q4 2015 Sep 15, 2017	BUY	N/A	7	7 $1,000

Others Institutions Holding CRL

# of Institutions

656

Shares Held

51.7M

Call Options Held

194K

Put Options Held

174K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.54B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account